NEOPLASM BY HISTOLOGY

Clinical trials for NEOPLASM BY HISTOLOGY explained in plain language.

Never miss a new study

Get alerted when new NEOPLASM BY HISTOLOGY trials appear

Sign up with your email to follow new studies for NEOPLASM BY HISTOLOGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Terminated trial tests Last-Chance drugs for tough kidney cancers

Disease control Terminated

This study tested two different drug combinations for people with advanced kidney cancer that had stopped responding to standard treatments. The trial aimed to find safe doses and see if these combinations could shrink tumors or slow disease progression. The study was terminated …

Matched conditions: NEOPLASM BY HISTOLOGY

Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

NEOPLASM BY HISTOLOGY

Get alerted when new NEOPLASM BY HISTOLOGY trials appear

Terminated trial tests Last-Chance drugs for tough kidney cancers